Skip to main content
HR 1725 114th Congress House Health Congressional oversight Criminal justice information and records Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Health programs administration and funding Health technology, devices, supplies Licensing and registrations Medical research Prescription drugs State and local government operations

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Introduced: September 8, 2015 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 9, 2015
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 8, 2015
Motion to reconsider laid on the table Agreed to without objection.
Sep 8, 2015
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5796-5797)
Sep 8, 2015
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5796-5797)
Sep 8, 2015
DEBATE - The House proceeded with forty minutes of debate on H.R. 1725.
Sep 8, 2015
Considered under suspension of the rules. (consideration: CR H5796-5798)
Sep 8, 2015
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Sep 8, 2015
Placed on the Union Calendar, Calendar No. 186.
Sep 8, 2015
Reported by the Committee on Energy and Commerce. H. Rept. 114-245.
Jul 29, 2015
Ordered to be Reported by Voice Vote.
Jul 29, 2015
Committee Consideration and Mark-up Session Held.
Jul 23, 2015
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jul 23, 2015
Subcommittee Consideration and Mark-up Session Held.
Mar 27, 2015
Referred to the Subcommittee on Health.
Mar 26, 2015
Referred to the House Committee on Energy and Commerce.
Mar 26, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

(Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
  • require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
  • expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

What's happening now September 9, 2015

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 4
  • S 480 Related bill National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
  • HR 3719 Related bill STOP ABUSE Act of 2015
  • HR 2805 Related bill Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015
  • S 524 Related bill Comprehensive Addiction and Recovery Act of 2016
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 8
All 8 Democratic 6 Republican 1
Comstock, Barbara
· Sep 8, 2015
 D
Moulton, Seth
Massachusetts · Jun 24, 2015
 D
Keating, William R.
Massachusetts · Jun 19, 2015
 D
Matsui, Doris O.
California · Jun 10, 2015
 R
Bilirakis, Gus M.
Florida · Jun 3, 2015
 D
Clark, Katherine M.
Massachusetts · Jun 1, 2015
 D
McGovern, James P.
Massachusetts · Jun 1, 2015
 D
Pallone, Frank
New Jersey · Mar 26, 2015
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1725: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-1725/
MLA
"H.R. 1725: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-1725/.
Bluebook (legal)
H.R. 1725, 114th Cong. (2026), https://openamerica.io/bill/114-HR-1725/.
Markdown link
[H.R. 1725: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015](https://openamerica.io/bill/114-HR-1725/)
Report a problem